Immunocore
IMCR
#5466
Rank
A$1.98 B
Marketcap
A$39.07
Share price
0.90%
Change (1 day)
-16.48%
Change (1 year)

Revenue for Immunocore (IMCR)

Revenue in 2025 (TTM): A$0.61 Billion

According to Immunocore's latest financial reports the company's current revenue (TTM ) is A$0.55 Billion. .The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunocore from 2020 to 2025

Annual revenue

Year Revenue Change
2025 A$0.59 B
2022 A$0.32 B369.51%
2021 A$68.35 M1.57%
2020 A$67.29 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA